Avid Bioservices Inc. (CDMO)

NASDAQ: CDMO · Real-Time Price · USD

12.49

0.00 (0.00%)

At close: Feb 04, 2025, 3:59 PM

Avid Bioservices Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Revenue	139.91M	149.27M	119.6M	95.87M	59.7M	53.6M	53.62M	57.63M	44.69M
Cost of Revenue	132.59M	117.79M	82.95M	66.56M	55.77M	46.38M	56.55M	38.26M	22.97M
Gross Profit	7.32M	31.48M	36.65M	29.31M	3.93M	7.22M	-2.92M	19.37M	21.72M
Operating Income	-18.68M	-2.61M	10.86M	8.92M	-10.59M	-5.62M	-20.64M	-28.26M	-56.36M
Interest Income	n/a	2.6M	2.68M	133K	474K	282K	102K	108K	722K
Pretax Income	-26.93M	2M	12.66M	11.21M	-10.47M	-5.34M	-20.56M	-28.16M	-55.65M
Net Income	-140.75M	560K	127.67M	11.21M	-7.26M	-4.21M	-21.81M	-28.16M	-55.65M
Selling & General & Admin	26M	27.88M	21.23M	17.06M	14.52M	12.85M	16.46M	19.33M	18.55M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	28.3M	59.53M
Other Expenses	1.00	1M	-81K	133K	355K	n/a	1.26M	n/a	n/a
Operating Expenses	26M	27.88M	21.23M	17.06M	14.52M	12.85M	16.46M	47.63M	78.08M
Interest Expense	4.34M	2.6M	2.68M	1.16M	8K	11K	27K	7K	14K
Selling & Marketing Expenses	800K	700K	600K	300K	200K	n/a	n/a	n/a	n/a
Cost & Expenses	158.59M	145.66M	104.17M	83.63M	70.29M	59.23M	73M	85.89M	101.05M
Income Tax Expense	113.83M	1.44M	-115.01M	-2.29M	-3.21M	-284K	-1.28M	-2.35M	722K
Shares Outstanding (Basic)	63.2M	62.27M	61.48M	58.22M	56.33M	55.98M	47.06M	37.11M	30.9M
Shares Outstanding (Diluted)	63.2M	63.78M	70.47M	59.43M	56.33M	55.98M	47.06M	37.11M	30.9M
EPS (Basic)	-2.23	0.01	2.08	0.06	-0.13	-0.08	-0.46	-0.76	-1.8
EPS (Diluted)	-2.23	0.01	1.81	0.06	-0.13	-0.08	-0.46	-0.76	-1.8
EBITDA	-11.48M	10.91M	19.9M	15.7M	-7.38M	-2.59M	-16.82M	3.75M	5.02M
EBIT	-22.59M	3.7M	15.42M	12.24M	-10.46M	-5.34M	-19.38M	1.29M	-55.65M
Depreciation & Amortization	11.11M	7.21M	4.48M	3.45M	3.09M	2.75M	2.56M	2.46M	1.53M